Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sage Therapeutics, Inc. | CFO & Treasurer | Common Stock | 81.4K | $729K | $8.96 | Aug 5, 2024 | Direct |
Sage Therapeutics, Inc. | CFO & Treasurer | Stock Option (Right to Buy) | 22.5K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SAGE | Sage Therapeutics, Inc. | Aug 5, 2024 | 2 | -$32.6K | 4 | Aug 7, 2024 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Feb 13, 2024 | 2 | $0 | 4 | Feb 15, 2024 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Jan 2, 2024 | 2 | $2.23K | 4 | Jan 4, 2024 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Nov 28, 2023 | 2 | -$18.2K | 4 | Nov 30, 2023 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Mar 15, 2023 | 2 | $4.08K | 4 | Mar 17, 2023 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Feb 21, 2023 | 4 | $1.36K | 4 | Feb 23, 2023 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Feb 13, 2023 | 1 | $0 | 4 | Feb 15, 2023 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Feb 3, 2023 | 2 | -$40.4K | 4 | Feb 7, 2023 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Jan 9, 2023 | 2 | $2.18K | 4 | Jan 11, 2023 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Jan 4, 2023 | 2 | $2.45K | 4 | Jan 5, 2023 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Feb 17, 2022 | 2 | $6.12K | 4 | Feb 18, 2022 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Feb 11, 2022 | 1 | $0 | 4 | Feb 15, 2022 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Nov 22, 2021 | 5 | $4.76K | 4 | Nov 23, 2021 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Oct 19, 2021 | 2 | -$41.3K | 4 | Oct 21, 2021 | CFO & Treasurer |
SAGE | Sage Therapeutics, Inc. | Jun 15, 2021 | 6 | -$41.5K | 4 | Jun 17, 2021 | CFO & Treasurer |